NM_000106.6:c.971A>C

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_000106.6(CYP2D6):​c.971A>C​(p.His324Pro) variant causes a missense change. The variant allele was found at a frequency of 0.000782 in 1,610,966 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign,other (★★).

Frequency

Genomes: 𝑓 0.00056 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00080 ( 31 hom. )

Consequence

CYP2D6
NM_000106.6 missense

Scores

3
8
7

Clinical Significance

Likely benign; other criteria provided, multiple submitters, no conflicts B:1O:1

Conservation

PhyloP100: 5.92

Publications

99 publications found
Variant links:
Genes affected
CYP2D6 (HGNC:2625): (cytochrome P450 family 2 subfamily D member 6) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]
NDUFA6-DT (HGNC:45273): (NDUFA6 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.020407856).
BP6
Variant 22-42127856-T-G is Benign according to our data. Variant chr22-42127856-T-G is described in ClinVar as Likely_benign|other. ClinVar VariationId is 39385.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 85 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000106.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP2D6
NM_000106.6
MANE Select
c.971A>Cp.His324Pro
missense
Exon 6 of 9NP_000097.3
CYP2D6
NM_001025161.3
c.818A>Cp.His273Pro
missense
Exon 5 of 8NP_001020332.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP2D6
ENST00000645361.2
MANE Select
c.971A>Cp.His324Pro
missense
Exon 6 of 9ENSP00000496150.1
CYP2D6
ENST00000359033.4
TSL:1
c.818A>Cp.His273Pro
missense
Exon 5 of 8ENSP00000351927.4
CYP2D6
ENST00000360124.10
TSL:1
n.*46A>C
non_coding_transcript_exon
Exon 5 of 8ENSP00000353241.6

Frequencies

GnomAD3 genomes
AF:
0.000569
AC:
86
AN:
151196
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000733
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00897
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000443
Gnomad OTH
AF:
0.000967
GnomAD2 exomes
AF:
0.00129
AC:
325
AN:
251012
AF XY:
0.00178
show subpopulations
Gnomad AFR exome
AF:
0.0000618
Gnomad AMR exome
AF:
0.000232
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000511
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000804
AC:
1174
AN:
1459654
Hom.:
31
Cov.:
36
AF XY:
0.00106
AC XY:
771
AN XY:
726114
show subpopulations
African (AFR)
AF:
0.0000300
AC:
1
AN:
33350
American (AMR)
AF:
0.000269
AC:
12
AN:
44670
Ashkenazi Jewish (ASJ)
AF:
0.000191
AC:
5
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39598
South Asian (SAS)
AF:
0.00775
AC:
667
AN:
86108
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53400
Middle Eastern (MID)
AF:
0.00226
AC:
13
AN:
5760
European-Non Finnish (NFE)
AF:
0.000385
AC:
428
AN:
1110352
Other (OTH)
AF:
0.000796
AC:
48
AN:
60280
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
91
181
272
362
453
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000562
AC:
85
AN:
151312
Hom.:
2
Cov.:
33
AF XY:
0.000716
AC XY:
53
AN XY:
73972
show subpopulations
African (AFR)
AF:
0.0000731
AC:
3
AN:
41040
American (AMR)
AF:
0.000197
AC:
3
AN:
15212
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5164
South Asian (SAS)
AF:
0.00898
AC:
43
AN:
4788
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10596
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000443
AC:
30
AN:
67746
Other (OTH)
AF:
0.000957
AC:
2
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000598
Hom.:
9
Bravo
AF:
0.000393
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000582
AC:
5
ExAC
AF:
0.00134
AC:
163
EpiCase
AF:
0.000764
EpiControl
AF:
0.000771

ClinVar

Significance: Likely benign; other
Submissions summary: Benign:1Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1Other:1
Aug 06, 2018
Eurofins Ntd Llc (ga)
Significance:other
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant classified as "other reportable" ??? variant is clinically benign (not associated with disease) but is reported when observed (e.g. pseudodeficiency alleles).

Apr 12, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.69
BayesDel_addAF
Benign
-0.091
T
BayesDel_noAF
Uncertain
-0.020
CADD
Uncertain
24
DANN
Benign
0.97
DEOGEN2
Benign
0.063
T
Eigen
Uncertain
0.53
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.78
T
M_CAP
Benign
0.072
D
MetaRNN
Benign
0.020
T
MetaSVM
Uncertain
0.55
D
MutationAssessor
Pathogenic
4.0
H
PhyloP100
5.9
PrimateAI
Uncertain
0.51
T
PROVEAN
Pathogenic
-7.7
D
REVEL
Benign
0.28
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.030
D
Vest4
0.59
MVP
0.84
MPC
0.65
ClinPred
0.24
T
GERP RS
3.4
Varity_R
0.79
gMVP
0.73
Mutation Taster
=48/52
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5030867; hg19: chr22-42523858; API